Novel Platforms for Preclinical Antibody Discovery

 11AM-12PM EDT | August 11, 2026 Antibodies are powerful preventive and therapeutic tools against microbes, cancers, autoimmune disorders, and many other diseases. However, traditional antibody discovery approaches often face major limitations, including low efficiency, high costs, high failure rates, logistical barriers, limited scalability, and long turnaround times. We are excited to invite Dr. Ivelin Georgiev to present his work on novel wet-lab and AI-based platforms designed to make preclinical antibody discovery more effective and efficient. In this webinar, Dr. Georgiev will discuss progress toward developing and validating integrated platforms for antibody discovery. He will highlight how these approaches can transform both the process and cost of identifying new monoclonal antibody drug candidates, while enabling the discovery of antibody phenotypes that have been challenging or even impossible to achieve using traditional methods.